Shopping Cart
Remove All
Your shopping cart is currently empty
Minocycline is a broad-spectrum and highly lipophilic tetracycline antibiotic with the advantages of being orally administrable and able to penetrate the blood-brain barrier. It binds to the 30S ribosomal subunit to inhibit protein synthesis, is effective against both Gram-positive and Gram-negative bacteria, and also has neuroprotective, anti-inflammatory, and antioxidant effects.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $899 | - | In Stock |
| Description | Minocycline is a broad-spectrum and highly lipophilic tetracycline antibiotic with the advantages of being orally administrable and able to penetrate the blood-brain barrier. It binds to the 30S ribosomal subunit to inhibit protein synthesis, is effective against both Gram-positive and Gram-negative bacteria, and also has neuroprotective, anti-inflammatory, and antioxidant effects. |
| In vitro | Ovarian cancer cell lines (OVCAR-3, SKOV-3, and A2780) were treated with minocycline (0-100 μM, 24-72 hours) to observe its effect on cell proliferation. Results: Minocycline inhibited the proliferation and colony formation activity of OVCAR-3, SKOV-3, and A2780 cells. [1] |
| In vivo | Methods: Minocycline (0-30 mg/kg, orally, once daily for 4 weeks) was used to treat female nude mice bearing OVCAR-3 tumor xenografts to investigate its inhibitory effect on tumors in mice. Results: Minocycline inhibited the growth of OVCAR-3 tumors in female nude mice. [1] |
| Molecular Weight | 457.48 |
| Formula | C23H27N3O7 |
| Cas No. | 10118-90-8 |
| Smiles | O[C@]12[C@]([C@H](N(C)C)C(O)=C(C(N)=O)C1=O)(C[C@]3(C(=C2O)C(=O)C=4C(C3)=C(N(C)C)C=CC4O)[H])[H] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 20 mg/mL (43.72 mM), Sonication is recommended. | |||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Saline: 2 mg/mL (4.37 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.